Engineers Gate Manager’s Vera Therapeutics VERA Stock Holding History

Engineers Gate Manager’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$259K	Buy	+6,440	New	+$277K	﹤0.01%	1784
2025 Q4	–	Sell	-22,138	Closed	-$643K	–	2578
2025 Q3	$643K	Buy	+22,138	New	+$512K	0.01%	1402
2025 Q2	–	Sell	-42,873	Closed	-$1.03M	–	2567
2025 Q1	$1.03M	Buy	+42,873	New	+$1.38M	0.02%	1041
2024 Q3	–	Sell	-19,524	Closed	-$706K	–	2429
2024 Q2	$706K	Buy	+19,524	New	+$774K	0.02%	1060

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Engineers Gate Manager's VERA Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Vera Therapeutics (VERA) in Q1 2026: 6,440 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #1784 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in VERA as recently as Q3 2025.

Engineers Gate Manager first reported a position in VERA in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.03M in Q1 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

Engineers Gate Manager held 6,440 shares of Vera Therapeutics worth $259K as of Q1 2026.
Vera Therapeutics was a new Engineers Gate Manager position in Q1 2026.
Vera Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1784 holding.
Engineers Gate Manager first reported a position in Vera Therapeutics in Q2 2024 and has held it in 4 quarters since.
Engineers Gate Manager's Vera Therapeutics position peaked at $1.03M in Q1 2025.
229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.